(S (S (NP (NN Neuroblastoma)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB strongly) (JJ heterogeneous)) (NN cancer)) (PP (IN with) (NP (NP (ADJP (RB very) (JJ diverse)) (JJ clinical) (NNS courses)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB vary) (PP (IN from) (NP (JJ spontaneous) (NN regression))) (PP (IN to) (NP (JJ fatal) (NN progression)))))))))))) (: ;) (S (NP (NP (NP (DT an) (JJ accurate) (NN patient) (POS 's)) (NN risk) (NN estimation)) (PP (IN at) (NP (NN diagnosis)))) (VP (VBZ is) (ADJP (JJ essential) (S (VP (TO to) (VP (VB design) (NP (JJ appropriate) (NML (NN tumor) (NN treatment)) (NNS strategies)))))))) (. .))
(S (NP (NN Neuroblastoma)) (VP (VBZ is) (NP (NP (DT a) (NN paradigm) (NN disease)) (SBAR (WHADVP (WRB where)) (S (NP (JJ different) (ADJP (JJ diagnostic) (CC and) (JJ prognostic)) (NNS endpoints)) (VP (MD should) (VP (VB be) (VP (VBN predicted) (PP (IN from) (NP (JJ common) (ADJP (JJ molecular) (CC and) (JJ clinical)) (NN information))) (, ,) (PP (IN with) (NP (VBG increasing) (NN complexity))) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN in) (NP (DT the) (NNP FDA) (NML (NNP MAQC) (HYPH -) (NNP II)) (NN study))))))))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP introduce) (NP (NP (NP (DT the) (JJ novel) (JJ multiobjective) (NML (JJ deep) (NN learning)) (NN architecture) (NN CDRP)) (-LRB- -LRB-) (NP (NNP Concatenated) (NNP Diagnostic) (NNP Relapse) (NNP Prognostic)) (-RRB- -RRB-)) (VP (VBN composed) (PP (IN by) (NP (CD 8) (NNS layers))) (S (VP (TO to) (VP (VB obtain) (NP (NP (DT a) (VBN combined) (ADJP (JJ diagnostic) (CC and) (JJ prognostic)) (NN prediction)) (PP (IN from) (NP (NML (JJ high) (HYPH -) (NN throughput)) (NNS transcriptomics) (NNS data)))))))))) (. .))
(S (NP (CD Two) (JJ distinct) (NN loss) (NNS functions)) (VP (VBP are) (VP (VBN optimized) (PP (IN for) (NP (NP (DT the) (NNP Event) (NNP Free) (NNP Survival)) (-LRB- -LRB-) (NP (NNP EFS)) (-RRB- -RRB-) (CC and) (NP (JJ Overall) (NN Survival) (-LRB- -LRB-) (NN OS) (-RRB- -RRB-) (NN prognosis)) (, ,) (ADVP (RB respectively)))))) (. .))
(S (NP (PRP We)) (VP (VBP use) (NP (NP (DT the) (NML (NML (JJ High) (HYPH -) (NN Risk)) (-LRB- -LRB-) (NML (NN HR)) (-RRB- -RRB-)) (JJ diagnostic) (NN information)) (PP (IN as) (NP (NP (DT an) (JJ additional) (NN input)) (VP (VBN generated) (PP (IN by) (NP (DT an) (NN autoencoder) (NN embedding)))))))) (. .))
(S (NP (DT The) (JJ latter)) (VP (VBZ is) (VP (VBN used) (PP (IN as) (NP (NN network) (NN regulariser))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ clinical) (NN algorithm)) (VP (ADVP (RB commonly)) (VBN adopted) (PP (IN for) (S (VP (VBG stratifying) (NP (NP (NP (NNS patients)) (PP (IN from) (NP (NN cancer) (NN stage)))) (, ,) (NP (NP (NN age)) (PP (IN at) (NP (NP (NN insurgence)) (PP (IN of) (NP (NN disease)))))) (, ,) (CC and) (NP (NP (NN MYCN)) (, ,) (NP (DT the) (JJ specific) (JJ molecular) (NN marker))))))))))))) (. .))
(S (NP (DT The) (NN architecture)) (VP (VBD was) (VP (VBN applied) (PP (IN to) (NP (NNP Illumina) (NNP HiSeq2000) (NN RNA) (HYPH -) (NN Seq))) (PP (IN for) (NP (NP (CD 498) (NN neuroblastoma) (NNS patients) (PRN (-LRB- -LRB-) (NP (NP (CD 176)) (PP (IN at) (NP (JJ high) (NN risk)))) (-RRB- -RRB-))) (PP (IN from) (NP (DT the) (NN Sequencing) (NML (NNP Quality) (NNP Control) (-LRB- -LRB-) (NNP SEQC) (-RRB- -RRB-)) (NN study))))) (, ,) (S (VP (VP (VBG obtaining) (NP (NP (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN art))))) (PP (IN on) (NP (DT the) (JJ diagnostic) (NN endpoint))))) (CC and) (VP (VBG improving) (NP (NP (NN prediction)) (PP (IN of) (NP (NP (NN prognosis)) (PP (IN over) (NP (DT the) (NN HR) (NN cohort))))))))))) (. .))
